haloperidol has been researched along with Childhood Tic Disorders in 67 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To determine the efficacy of adding haloperidol to the treatment of patients with obsessive-compulsive disorder (OCD), with or without a comorbid chronic tic disorder, who were refractory to adequate treatment with the serotonin-uptake inhibitor fluvoxamine alone." | 9.07 | Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics. ( Goodman, WK; Heninger, GR; Leckman, JF; Lee, NC; McDougle, CJ; Price, LH, 1994) |
| "The relationship between a medication course with haloperidol (Haldol) and family history for any type of tics was examined in a survey of 196 Tourette syndrome patients." | 7.67 | Treating Tourette syndrome with haloperidol: predictors of success. ( Konkol, RJ; Schwabe, MJ, 1989) |
| "Nicotine was found to markedly potentiate haloperidol-induced hypokinesia in rats." | 5.28 | Nicotine potentiates the effects of haloperidol in animals and in patients with Tourette syndrome. ( Blythe, MM; Fogelson, HM; Klykylo, WM; Manderscheid, PZ; McConville, BJ; Norman, AB; Parker, KW; Sanberg, PR, 1989) |
| "To determine the efficacy of adding haloperidol to the treatment of patients with obsessive-compulsive disorder (OCD), with or without a comorbid chronic tic disorder, who were refractory to adequate treatment with the serotonin-uptake inhibitor fluvoxamine alone." | 5.07 | Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics. ( Goodman, WK; Heninger, GR; Leckman, JF; Lee, NC; McDougle, CJ; Price, LH, 1994) |
| "The relationship between a medication course with haloperidol (Haldol) and family history for any type of tics was examined in a survey of 196 Tourette syndrome patients." | 3.67 | Treating Tourette syndrome with haloperidol: predictors of success. ( Konkol, RJ; Schwabe, MJ, 1989) |
| " Case 1 is a description of the subjective experience of a patient with acute orofacial dystonia from promethazine." | 3.66 | Case vignettes of movement disorders. ( Yung, CY, 1983) |
| "Das Bewusstsein der Öffentlichkeit für Tic-Störungen und insbesondere für das Tourette-Syndrom ist durch zahlreiche Medienbeiträge in den letzten Jahren gestiegen." | 2.61 | [Patients with tic disorders: widely known, yet underserved]. ( Musil, R; Schnell, JML; Weidinger, E, 2019) |
| "Aripiprazole was generally well tolerated in children and adolescents." | 2.61 | Safety of aripiprazole for tics in children and adolescents: A systematic review and meta-analysis. ( Cui, H; Mao, J; Yang, C; Yi, Q; Zhang, L, 2019) |
| "Sydenham's chorea is a symptom of rheumatic fever and results from an autoimmune attack on the CNS." | 2.39 | Neuropsychiatric aspects of Sydenham's chorea: a comprehensive review. ( Moore, DP, 1996) |
| "Treatment with haloperidol is useful for 80% to 85% of patients but associated with troublesome side effects in one-half of those treated." | 2.36 | Tics in childhood. ( Golden, GS, 1983) |
| "A total of 154 children with tic disorder co-morbid with attention deficit hyperactivity disorder admitted to our hospital from July 2019 to July 2022 were recruited and assigned to receive either methylphenidate hydrochloride plus haloperidol (observation group) or clonidine (experimental group), with 77 cases in each group." | 1.91 | Efficacy of clonidine in the treatment of children with tic disorder co-morbid with attention deficit hyperactivity disorder. ( Hu, B; Huang, XH; Wang, GL; Yuan, Y; Zeng, KD; Zhang, W, 2023) |
| "Risperidone has been proved on efficacy for tic disorders but EPS still remain, even though it was claimed to be less." | 1.31 | Quetiapine for tic disorder: a case report. ( Boonyanaruthee, V; Chan-Ob, T; Kuntawongse, N, 2001) |
| "Two patients suffering from Tourette's Syndrome who had developed episodes of continual motor tics that lasted from minutes to hours, were non-suppressible and intruded into normal functioning, were treated with an increase in the dose of haloperidol, in one case with the addition of clonazepam." | 1.29 | Tics status. ( Chee, KY; Sachdev, P; Wilson, A, 1996) |
| "Nicotine was found to markedly potentiate haloperidol-induced hypokinesia in rats." | 1.28 | Nicotine potentiates the effects of haloperidol in animals and in patients with Tourette syndrome. ( Blythe, MM; Fogelson, HM; Klykylo, WM; Manderscheid, PZ; McConville, BJ; Norman, AB; Parker, KW; Sanberg, PR, 1989) |
| "Therapeutic plasma monitoring of haloperidol, a major neuroleptic, measured by radioimmunoassay, has shown a rather good correlation between plasma level and dosage but with large interindividual variation in children as in adults; age seems not to have any effect on haloperidol metabolism." | 1.27 | [Haloperidol. Plasma monitoring and hormonal effects of treatment]. ( Debray, Q; Dugas, M; Giraud, J; Goyot, C; Grenier, J; Guay, C, 1985) |
| "We report a patient in whom Tourette's syndrome (TS) and Type I schizophrenia coincided, and suggest, based on clinical features and pharmacological responses, that both conditions in this patient could have a common pathophysiological basis." | 1.27 | Gilles de la Tourette's syndrome associated with chronic schizophrenia. ( Bamford, CR; Sandyk, R, 1988) |
| "The authors hypothesize that tic disorders in individuals with PDD may be a marker for a more positive response to dopamine antagonists like haloperidol." | 1.27 | A treatable language disorder: pharmacological treatment of pervasive developmental disorder. ( Burd, L; Fisher, W; Kerbeshian, J, 1986) |
| "Nine of them had generalized tic (Gilles de la Tourette's disease), and 43 had local forms." | 1.26 | [Pathogenesis and treatment of tic-type hyperkinesis in children]. ( Blagosklonov, AV; Bondarenko, ES; Lebedev, VN; Malyshev, IuI, 1981) |
| "Treatment with haloperidol is effective but associated with a high incidence of side effects." | 1.26 | Tics and tremors. ( Golden, GS; Hood, OJ, 1982) |
| "Six cases of Gilles de la Tourette's syndrome are discussed in the light of conflicting views on the aetiology of the condition." | 1.26 | Six cases of Gilles de la Tourette's syndrome. ( Fernando, SJ, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 45 (67.16) | 18.7374 |
| 1990's | 10 (14.93) | 18.2507 |
| 2000's | 5 (7.46) | 29.6817 |
| 2010's | 5 (7.46) | 24.3611 |
| 2020's | 2 (2.99) | 2.80 |
| Authors | Studies |
|---|---|
| Zeng, KD | 1 |
| Wang, GL | 1 |
| Yuan, Y | 1 |
| Zhang, W | 1 |
| Huang, XH | 1 |
| Hu, B | 1 |
| Schnell, JML | 1 |
| Weidinger, E | 1 |
| Musil, R | 1 |
| Qian, HL | 1 |
| Yu, X | 1 |
| Liu, GF | 1 |
| Guo, JM | 1 |
| Shi, XX | 1 |
| Yang, SW | 1 |
| Qian, QF | 1 |
| Huang, Y | 1 |
| Xie, YQ | 1 |
| Ou, P | 1 |
| Yang, C | 1 |
| Yi, Q | 1 |
| Zhang, L | 1 |
| Cui, H | 1 |
| Mao, J | 1 |
| Yang, CS | 1 |
| Huang, H | 1 |
| Zhang, LL | 1 |
| Zhu, CR | 1 |
| Guo, Q | 1 |
| Wu, M | 1 |
| Xiao, GH | 1 |
| Yao, M | 1 |
| Zhang, JM | 1 |
| Zhang, X | 1 |
| Zhou, YB | 1 |
| Zhang, JY | 1 |
| Wang, SX | 1 |
| Ma, B | 1 |
| Chen, YP | 1 |
| Yoo, HK | 1 |
| Lee, JS | 1 |
| Paik, KW | 1 |
| Choi, SH | 1 |
| Yoon, SJ | 1 |
| Kim, JE | 1 |
| Hong, JP | 1 |
| Kano, Y | 1 |
| Bloch, MH | 1 |
| Landeros-Weisenberger, A | 1 |
| Kelmendi, B | 1 |
| Coric, V | 1 |
| Bracken, MB | 1 |
| Leckman, JF | 6 |
| Tolosa Sarró, E | 1 |
| Bayés Rusiñol, A | 1 |
| Muñoz Yunta, JA | 1 |
| Gillies, DR | 1 |
| Forsythe, WI | 1 |
| Cohen, DJ | 4 |
| Golden, GS | 2 |
| Caine, ED | 2 |
| Ludlow, CL | 1 |
| Polinsky, RJ | 1 |
| Ebert, MH | 1 |
| Lakke, JP | 1 |
| Yung, CY | 1 |
| Mizes, JS | 1 |
| Bondarenko, ES | 1 |
| Malyshev, IuI | 1 |
| Blagosklonov, AV | 1 |
| Lebedev, VN | 1 |
| Hood, OJ | 1 |
| Singer, HS | 1 |
| Nomura, Y | 1 |
| Segawa, M | 1 |
| McDougle, CJ | 2 |
| Goodman, WK | 2 |
| Price, LH | 2 |
| Lee, NC | 1 |
| Heninger, GR | 1 |
| Sachdev, P | 1 |
| Chee, KY | 1 |
| Wilson, A | 1 |
| Moore, DP | 1 |
| Arzimanoglou, AA | 1 |
| Saccomani, L | 1 |
| Rizzo, P | 1 |
| Nobili, L | 1 |
| Chan-Ob, T | 1 |
| Kuntawongse, N | 1 |
| Boonyanaruthee, V | 1 |
| Calne, DB | 1 |
| Eisler, T | 1 |
| Barker, P | 1 |
| Fernando, SJ | 1 |
| Diaz, JM | 1 |
| Smith, KG | 1 |
| Maccario, M | 1 |
| Riddle, MA | 1 |
| Wasserstein, PH | 1 |
| Honig, LS | 1 |
| Stárková, L | 2 |
| Wiedermann, J | 1 |
| Siemers, E | 1 |
| Pascuzzi, R | 1 |
| Mrna, B | 1 |
| Sanberg, PR | 1 |
| McConville, BJ | 1 |
| Fogelson, HM | 1 |
| Manderscheid, PZ | 1 |
| Parker, KW | 1 |
| Blythe, MM | 1 |
| Klykylo, WM | 1 |
| Norman, AB | 1 |
| Schwabe, MJ | 1 |
| Konkol, RJ | 1 |
| Price, RA | 2 |
| Pauls, DL | 2 |
| Kidd, KK | 2 |
| Gualtieri, CT | 1 |
| Patterson, DR | 1 |
| Aksent'ev, SB | 1 |
| Borisova, NP | 1 |
| Levinskiĭ, MV | 1 |
| Kryzhanovskiĭ, GN | 1 |
| Goyot, C | 1 |
| Debray, Q | 1 |
| Dugas, M | 1 |
| Guay, C | 1 |
| Giraud, J | 1 |
| Grenier, J | 1 |
| Troung, DD | 1 |
| Bressman, S | 1 |
| Shale, H | 1 |
| Fahn, S | 1 |
| McBride, MC | 1 |
| Chiverton, P | 1 |
| Bamford, KA | 1 |
| Rediess, S | 1 |
| Shiao, J | 1 |
| Erenberg, G | 2 |
| Sandyk, R | 1 |
| Bamford, CR | 1 |
| Cruse, RP | 1 |
| Rothner, AD | 1 |
| Fisher, W | 1 |
| Kerbeshian, J | 1 |
| Burd, L | 1 |
| Casat, CD | 1 |
| Wilson, DC | 1 |
| Beckers, W | 1 |
| Still, CN | 1 |
| Ham, CH | 1 |
| Marsden, CD | 1 |
| Sand, PL | 1 |
| Carlson, C | 1 |
| Shapiro, AK | 1 |
| Shapiro, E | 1 |
| Gadoth, N | 1 |
| de Morsier, G | 1 |
| Nagyová, H | 1 |
| Novotný, V | 1 |
| Tapia, F | 1 |
| Wells, PG | 1 |
| Malcolm, MT | 1 |
| Lucas, AR | 1 |
| Connell, PH | 1 |
| Corbett, JA | 1 |
| Horne, DJ | 1 |
| Mathews, AM | 1 |
| Varma, SC | 1 |
| Kemph, JP | 1 |
| Gilbert, MM | 1 |
| Fiume, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Quetiapine Augmentation Versus Clomipramine Augmentation of Selective Serotonin Reuptake Inhibitors for Obsessive-compulsive Disorder Patients That do Not Respond to a SSRI Trial: a Randomized Open-trial.[NCT00564564] | Phase 4 | 21 participants (Actual) | Interventional | 2006-01-31 | Completed | ||
| Ketamine Treatment for Pediatric-Refractory Obsessive-Compulsive Disorder (OCD)[NCT02422290] | Phase 1/Phase 2 | 5 participants (Actual) | Interventional | 2015-03-31 | Completed | ||
| An Open-Label Trial of Epidiolex in the Treatment of Obsessive Compulsive Disorder and Related Disorders: Proof of Concept Study[NCT04978428] | Phase 2 | 15 participants (Anticipated) | Interventional | 2022-04-14 | Recruiting | ||
| Open Label Study for the Use of Transcranial Ultrasound Treatment of Obsessive-Compulsive Disorder[NCT04775875] | 30 participants (Anticipated) | Interventional | 2020-12-01 | Enrolling by invitation | |||
| [NCT00004325] | 200 participants | Observational | 1988-12-31 | Completed | |||
| Initial Evaluation of Efficacy and Adverse Events of Single Lesions in Bilateral Ventral-capsular and Ventral Capsulotomy-striatal by Linear Accelerator Radiosurgery in Severe and Refractory Obsessive-compulsive Disorder[NCT02500888] | 10 participants (Anticipated) | Interventional | 2015-06-30 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
The CY-BOCS is a semi-structured measure of OCD severity with excellent inter-rater reliability, internal consistency, and test-retest reliability. It is validated in those starting at age 7 and used in studies up to age 20. The CYBOCS differs from the adult YBOCS only in its use of simpler language. The CY-BOCS consists of 10 items which are summed up to derive the total CY-BOCS score. The total score ranges from 0-40 with higher scores indicating greater severity of OCD symptoms. (NCT02422290)
Timeframe: Screening, Baseline, Day 7, Day 17, 3-Month; Baseline and Day 14 pre-specified to be reported
| Intervention | score on a scale (Mean) | |
|---|---|---|
| CY-BOCS Baseline | CY-BOCS Day 14 | |
| Ketamine Treatment Group | 29.00 | 26.20 |
The CGI-S is a clinician rated 7-point rating scale for the severity of a participant's illness relative to the clinician's experience of working with this particular population. The score ranges from 1-7 with higher scores indicating greater illness severity. (NCT02422290)
Timeframe: Screening, Baseline, Day 7, Day 17, 3-Month; Baseline and Day 14 pre-specified to be reported
| Intervention | score on a scale (Mean) | |
|---|---|---|
| CGI-S Baseline | CGI-S Day 14 | |
| Ketamine Treatment Group | 5.80 | 5.00 |
"The OCD-VAS is a one-item unipolar scale to assess OCD symptoms over a rapid time frame (No obsessions to Constant obsessions). The scale ranges from 0-10 with higher scores indicating higher presence of obsessions." (NCT02422290)
Timeframe: Screening, Baseline, Day 1-14, 3-Month; Baseline and Day 14 pre-specified to be reported
| Intervention | score on a scale (Mean) | |
|---|---|---|
| OCD-VAS Baseline | OCD-VAS Day 14 | |
| Ketamine Treatment Group | 5.00 | 5.00 |
"The Y-BOCCS is self-report scale which assesses OCD symptoms on a 5-point likert scale (None to Extreme). It consists of 10 items which are summed up to derive the total Y-BOCCS score. The total score ranges from 0-40 with higher scores indicating higher prevalence of OCD symptoms." (NCT02422290)
Timeframe: Screening, Baseline, Day 1-14, 3-Month; Baseline and Day 14 pre-specified to be reported
| Intervention | score on a scale (Mean) | |
|---|---|---|
| Y-BOCCS Baseline | Y-BOCCS Day 14 | |
| Ketamine Treatment Group | 18.25 | 16.50 |
14 reviews available for haloperidol and Childhood Tic Disorders
| Article | Year |
|---|---|
[Patients with tic disorders: widely known, yet underserved].
Topics: Europe; Haloperidol; Humans; Off-Label Use; Tic Disorders; Tics; Tourette Syndrome | 2019 |
Safety of aripiprazole for tics in children and adolescents: A systematic review and meta-analysis.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Child; Haloperidol; Humans; Randomized Controlled Tr | 2019 |
Aripiprazole for the treatment of tic disorders in children: a systematic review and meta-analysis.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Child; Child, Preschool; Haloperidol; Humans; Random | 2015 |
[Chronic tic disorders--chronic mortor or vocal tic disorders and de la Tourette's syndrome].
Topics: Adolescent; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Central Nervous Sy | 2003 |
A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder.
Topics: Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Comorbidity; Depressive | 2006 |
A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder.
Topics: Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Comorbidity; Depressive | 2006 |
A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder.
Topics: Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Comorbidity; Depressive | 2006 |
A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder.
Topics: Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Comorbidity; Depressive | 2006 |
A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder.
Topics: Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Comorbidity; Depressive | 2006 |
A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder.
Topics: Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Comorbidity; Depressive | 2006 |
A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder.
Topics: Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Comorbidity; Depressive | 2006 |
A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder.
Topics: Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Comorbidity; Depressive | 2006 |
A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder.
Topics: Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Comorbidity; Depressive | 2006 |
A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder.
Topics: Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Comorbidity; Depressive | 2006 |
A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder.
Topics: Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Comorbidity; Depressive | 2006 |
A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder.
Topics: Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Comorbidity; Depressive | 2006 |
A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder.
Topics: Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Comorbidity; Depressive | 2006 |
A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder.
Topics: Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Comorbidity; Depressive | 2006 |
A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder.
Topics: Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Comorbidity; Depressive | 2006 |
A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder.
Topics: Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Comorbidity; Depressive | 2006 |
[Gilles de la Tourette's syndrome: diagnosis, pathogenesis and treatment].
Topics: Adolescent; Adult; Child; Child, Preschool; Diagnosis, Differential; Female; Haloperidol; Humans; Ma | 1983 |
Treatment of multiple tics and the Tourette syndrome.
Topics: Adolescent; Antipsychotic Agents; Benztropine; Child; Child, Preschool; Clonidine; Haloperidol; Huma | 1984 |
Recent advances in Gilles de la Tourette syndrome: implications for clinical practice and future research.
Topics: Adolescent; Age Factors; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Compulsive | 1983 |
Tics in childhood.
Topics: Child; Chronic Disease; Female; Haloperidol; Humans; Male; Prognosis; Tic Disorders; Tourette Syndro | 1983 |
Dopamine antagonists in tic-related and psychotic spectrum obsessive compulsive disorder.
Topics: Adult; Antipsychotic Agents; Clinical Trials as Topic; Clomipramine; Clozapine; Dopamine Antagonists | 1994 |
Neuropsychiatric aspects of Sydenham's chorea: a comprehensive review.
Topics: Adult; Autoimmune Diseases; Chorea; Comorbidity; Haloperidol; Humans; Mental Disorders; Obsessive-Co | 1996 |
Gilles de la Tourette syndrome.
Topics: Child; Cholinergic Antagonists; Haloperidol; Humans; Tic Disorders; Tourette Syndrome | 1998 |
The pathogensis and medical treatment of extrapyramidal disease.
Topics: Adult; Athetosis; Basal Ganglia Diseases; Caudate Nucleus; Chorea; Corpus Striatum; Dopamine; Dopami | 1979 |
Pharmacotherapy of Tourette's syndrome and associated disorders.
Topics: Attention Deficit Disorder with Hyperactivity; Clonidine; Female; Haloperidol; Humans; Male; Mental | 1992 |
8 trials available for haloperidol and Childhood Tic Disorders
| Article | Year |
|---|---|
[Efficacy of clonidine transdermal patch in treatment of moderate to severe tic disorders in children].
Topics: Child; Child, Preschool; Clonidine; Female; Haloperidol; Humans; Male; Severity of Illness Index; Ti | 2017 |
Multicenter clinical study on the treatment of children's tic disorder with Qufeng Zhidong Recipe.
Topics: Antiparkinson Agents; Antipsychotic Agents; Child; Child, Preschool; Cookbooks as Topic; Drug Therap | 2009 |
Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics.
Topics: Adolescent; Adult; Age of Onset; Behavior Therapy; Comorbidity; Double-Blind Method; Drug Therapy, C | 1994 |
Combined treatment with haloperidol and trazodone in patients with tic disorders.
Topics: Adolescent; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Child; Drug Therapy, Com | 2000 |
Clonazepam, haloperidol, and clonidine in tic disorders.
Topics: Child; Clinical Trials as Topic; Clonazepam; Clonidine; Drug Therapy, Combination; Dyskinesia, Drug- | 1988 |
Haldol in the treatment of children with tics and stutterers and an incidental finding.
Topics: Child; Child, Preschool; Clinical Trials as Topic; Haloperidol; Humans; Placebos; Stuttering; Tic Di | 1969 |
Controlled trial of the treatment of 36 stutterers.
Topics: Adolescent; Adult; Clinical Trials as Topic; Female; Haloperidol; Humans; Intelligence Tests; Male; | 1971 |
Drug treatment of adolescent tiqueurs. A double-blind trial of Diazepam and Haloperidol.
Topics: Adolescent; Child; Clinical Trials as Topic; Diazepam; Haloperidol; Humans; Male; Placebos; Tic Diso | 1967 |
45 other studies available for haloperidol and Childhood Tic Disorders
| Article | Year |
|---|---|
Efficacy of clonidine in the treatment of children with tic disorder co-morbid with attention deficit hyperactivity disorder.
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clonidine; | 2023 |
Silver(I) Coordination Polymers: Photocatalytic Properties and Enhanced Treatment Activity of Haloperidol on Children Tic Disorder by Regulating Neurotransmitter Content.
Topics: Catalysis; Child; Coordination Complexes; Drug Synergism; Gene Expression Regulation; Haloperidol; H | 2020 |
Open-label study comparing the efficacy and tolerability of aripiprazole and haloperidol in the treatment of pediatric tic disorders.
Topics: Adolescent; Aripiprazole; Child; Female; Haloperidol; Humans; Male; Piperazines; Quinolones; Severit | 2011 |
Provocative drug testing in Tourette's syndrome: d- and l-amphetamine and haloperidol.
Topics: Adolescent; Adult; Amphetamine; Child; Dextroamphetamine; Female; Haloperidol; Humans; Male; Tic Dis | 1984 |
[Gilles de la Tourette's disease. 'Such a beautiful name for an awful disease'].
Topics: Adolescent; Adult; Child; Female; Haloperidol; Humans; Male; Tic Disorders; Tourette Syndrome | 1984 |
Case vignettes of movement disorders.
Topics: Adult; Amantadine; Brain Injuries; Clonazepam; Diagnosis, Differential; Dystonia; Female; Haloperido | 1983 |
Phobic behavior after haloperidol withdrawal.
Topics: Adolescent; Blinking; Haloperidol; Humans; Male; Phobic Disorders; Stereotyped Behavior; Substance W | 1984 |
[Pathogenesis and treatment of tic-type hyperkinesis in children].
Topics: Adolescent; Child; Drug Therapy, Combination; Electroencephalography; Electronystagmography; Female; | 1981 |
Tics and tremors.
Topics: Adolescent; Child; Child, Preschool; Ethnicity; Female; Haloperidol; Humans; Male; Propranolol; Tic | 1982 |
Tics and Tourette syndrome.
Topics: Adolescent; Adult; Child; Child, Preschool; Dopamine; Female; Haloperidol; Homovanillic Acid; Humans | 1982 |
Tourette syndrome in oriental children: clinical and pathophysiological considerations.
Topics: Adolescent; Asian People; Child; Child, Preschool; Female; Haloperidol; Humans; Levodopa; Male; Pimo | 1982 |
Tics status.
Topics: Adolescent; Adult; Antipsychotic Agents; Clozapine; Dose-Response Relationship, Drug; Drug Administr | 1996 |
Quetiapine for tic disorder: a case report.
Topics: Adult; Antipsychotic Agents; Dibenzothiazepines; Female; Haloperidol; Humans; Quetiapine Fumarate; R | 2001 |
Haloperidol.
Topics: Child; Child, Preschool; Haloperidol; Humans; Hyperkinesis; Intellectual Disability; Stuttering; Tic | 1975 |
Six cases of Gilles de la Tourette's syndrome.
Topics: Adult; Behavior Therapy; Drive; Drug Tolerance; Female; Haloperidol; Humans; Male; Parent-Child Rela | 1976 |
Exacerbation of motor tic and induction of new tic by haloperidol use.
Topics: Adult; Haloperidol; Humans; Male; Tic Disorders | 1992 |
Tic or dystonia?
Topics: Adult; Diagnosis, Differential; Dystonia; Haloperidol; Humans; Tic Disorders; Torticollis | 1992 |
Our experience with incisive neuroleptic drugs in child psychiatry.
Topics: Antipsychotic Agents; Autistic Disorder; Child; Haloperidol; Humans; Mental Disorders; Obsessive-Com | 1991 |
Posttraumatic tic disorder.
Topics: Adult; Craniocerebral Trauma; Haloperidol; Humans; Male; Pimozide; Tic Disorders | 1990 |
Incisive neuroleptic drugs in child psychiatry.
Topics: Antipsychotic Agents; Child; Child Psychiatry; Haloperidol; Humans; Obsessive-Compulsive Disorder; P | 1989 |
Nicotine potentiates the effects of haloperidol in animals and in patients with Tourette syndrome.
Topics: Adolescent; Animals; Behavior, Animal; Catalepsy; Chewing Gum; Child; Child, Preschool; Drug Interac | 1989 |
Treating Tourette syndrome with haloperidol: predictors of success.
Topics: Adolescent; Female; Haloperidol; Humans; Male; Probability; Retrospective Studies; Sex Factors; Tic | 1989 |
Gilles de la Tourette's syndrome: tics and central nervous system stimulants in twins and nontwins.
Topics: Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulan | 1986 |
Neuroleptic-induced tics in two hyperactive children.
Topics: Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Child; Dextroamphetamine; Halop | 1986 |
[Complex use of benzodiazepines, lithium salts and haloperidol in the treatment of obsessive movements and tics of different origin].
Topics: Adolescent; Anti-Anxiety Agents; Benzodiazepines; Child; Child, Preschool; Compulsive Behavior; Drug | 1987 |
[Haloperidol. Plasma monitoring and hormonal effects of treatment].
Topics: Administration, Oral; Adolescent; Adult; Age Factors; Aged; beta-Endorphin; Child; Delayed-Action Pr | 1985 |
Tourette's syndrome in Monroe County school children.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Behavior; Child; Child, Preschool; Clonid | 1988 |
Pharmacologic therapy of tics in childhood.
Topics: Adolescent; Adult; Child; Clonazepam; Clonidine; Haloperidol; Humans; Pimozide; Tic Disorders; Toure | 1988 |
Gilles de la Tourette's syndrome associated with chronic schizophrenia.
Topics: Adolescent; Chronic Disease; Hallucinations; Haloperidol; Humans; Male; Naltrexone; Schizophrenia, P | 1988 |
The natural history of Tourette syndrome: a follow-up study.
Topics: Adaptation, Psychological; Adolescent; Adolescent Behavior; Adult; Aging; Clonidine; Fluphenazine; F | 1987 |
A treatable language disorder: pharmacological treatment of pervasive developmental disorder.
Topics: Child; Child Development Disorders, Pervasive; Haloperidol; Humans; Language Disorders; Middle Aged; | 1986 |
A twin study of Tourette syndrome.
Topics: Adolescent; Adult; Age Factors; Aged; Child; Diseases in Twins; Female; Haloperidol; Humans; Male; M | 1985 |
Tics with combined thioridazine-methylphenidate therapy: case report.
Topics: Child; Drug Therapy, Combination; Haloperidol; Humans; Male; Methylphenidate; Receptors, Dopamine; T | 1986 |
[Gilles de la Tourette's disease based on five own observations].
Topics: Adolescent; Adult; Basal Ganglia Diseases; Compulsive Behavior; Diazepam; Dibenzocycloheptenes; Echo | 1973 |
Vesta variant of Tourette's disease: treatment with haloperidol.
Topics: Administration, Oral; Female; Haloperidol; Humans; Middle Aged; MMPI; Stress, Psychological; Tic Dis | 1973 |
Drug treatment of diseases characterized by abnormal movements.
Topics: Chorea; Diazepam; Ethanol; Haloperidol; Humans; Huntington Disease; Levodopa; Movement Disorders; My | 1973 |
Failure to establish control over tics in the Gilles de la Tourette syndrome with behaviour therapy techniques.
Topics: Behavior Therapy; Child; Evaluation Studies as Topic; Haloperidol; Humans; Male; Motor Activity; Pra | 1973 |
Gilles de la Tourette's syndrome.
Topics: Adolescent; Brain Damage, Chronic; Child; Child, Preschool; Echolalia; Female; Haloperidol; Humans; | 1974 |
[Gilles de la Tourette's syndrome].
Topics: Brain Chemistry; Catecholamines; Corpus Striatum; Dextroamphetamine; Haloperidol; Humans; Norepineph | 1974 |
[Tic. Study of 11 cases].
Topics: Adolescent; Adult; Age Factors; Bronchopneumonia; Child; Female; Fever; Follow-Up Studies; Haloperid | 1972 |
Drug treatment of tic and hyperkinesia in children.
Topics: Child; Child Behavior Disorders; Child, Preschool; Haloperidol; Humans; Hyperkinesis; Tic Disorders | 1973 |
Gilles de la Tourette's disease. An overview.
Topics: Haloperidol; Humans; Tic Disorders; Tourette Syndrome | 1970 |
The use of haloperidol in the treatment of a psychotic child with multiple tics.
Topics: Child; Haloperidol; Humans; Male; Neurocognitive Disorders; Tic Disorders | 1971 |
Haloperidol in severe facial dyskinesia. Case report.
Topics: Face; Female; Haloperidol; Humans; Middle Aged; Tic Disorders | 1969 |
[On the pharmacological effects of an association of haloperidol and isopropamide bromide].
Topics: Anxiety; Depression; Female; Haloperidol; Humans; Male; Neurasthenia; Neurotic Disorders; Parasympat | 1966 |